Also, during this timeframe the Apple “App” store added approximately 1 million apps for the iPhone.
Additional reasons for the sluggish adoption of e-technology include the limited empirical evidence on whether e-technologies improve or enhance the design of clinical trials and the paucity of regulatory guidance and policies, particularly when FDA-approval is required.